New drugs for treatment of tuberculosis

Der Internist
T Schaberg

Abstract

New effective drugs for the treatment of tuberculosis (TB) are necessary for two main reasons: firstly, it would be desirable to reduce the duration of TB treatment from 6 to 4 months and secondly, new drugs are urgently needed for the treatment of multidrug-resistant strains of Mycobacterium tuberculosis. For the first time since 1960 the two new drugs bedaquiline and delamanid were approved and licensed in 2014 for the treatment of multidrug-resistant M. tuberculosis; however, efforts to reduce the duration of treatment to 4 months using fluoroquinolones have not been successful. Further new drugs are currently in phase 2 and phase 3 studies; therefore, new treatment options can be expected within the next few years.

References

Feb 25, 1993·The New England Journal of Medicine·T R FriedenS W Dooley
Dec 22, 2006·Journal of Medicinal Chemistry·Hirofumi SasakiHidetsugu Tsubouchi
Jun 6, 2009·The New England Journal of Medicine·Andreas H DiaconDavid F Mc Neeley
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Aug 11, 2011·The European Respiratory Journal·D FalzonM Zignol
Mar 21, 2012·Antimicrobial Agents and Chemotherapy·Andreas H DiaconMelvin K Spigelman
Jun 8, 2012·The New England Journal of Medicine·Maria Tarcela GlerCharles D Wells
Sep 29, 2012·The European Respiratory Journal·Vija SkripconokaCharles D Wells
Oct 19, 2012·The New England Journal of Medicine·Myungsun LeeClifton E Barry
May 20, 2014·Bulletin of the World Health Organization·Giovanni Battista Migliori, Fiona Fleck
Aug 21, 2014·The New England Journal of Medicine·Andreas H DiaconUNKNOWN TMC207-C208 Study Group
Sep 10, 2014·The New England Journal of Medicine·Stephen H GillespieUNKNOWN REMoxTB Consortium
Sep 23, 2014·The European Respiratory Journal·Shenjie TangZhanjun Zhang
Oct 23, 2014·The New England Journal of Medicine·Corinne S MerleUNKNOWN OFLOTUB/Gatifloxacin for Tuberculosis Project
Jan 2, 2015·The European Respiratory Journal·Timo WeissHolger Rüssmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

The New England Journal of Medicine
Guido V BloembergErik C Böttger
American Journal of Respiratory and Critical Care Medicine
Prasanta Raghab Mohapatra
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
Rajesh GuptaCharles D Wells
© 2022 Meta ULC. All rights reserved